Brand name: Prolastin-C TM
Active ingredients: alpha-1-proteinase inhibitor
What it is used for
PROLASTIN-C is an alpha-1-proteinase inhibitor (human, Alpha1-PI) indicated to increase serum Alpha1-PI levels in adults with congenital deficiency of alpha-1 antitrypsin and with clinically significant emphysema (FEV1 less than 80%). The data for clinical efficacy of PROLASTIN-C is derived from changes in the biomarkers alpha-1 anti-protease level and CT lung density. Efficacy on FEV1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials. Clinical trials have only included patients who were not smoking.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Powder
A white to beige-colored lyophilised powder
The way to take this medicine is: Intravenous Infusion.
Part 2: Diluent, not applicable
Clear, colorless and practically free of particles
The way to take this medicine is: Intravenous Infusion.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 36 Months.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient alpha-1-proteinase inhibitor
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems